What are we even talking about?
If you are looking into peptides that nudge your body to release more Growth Hormone (GH), you have likely stumbled across Ipamorelin and Sermorelin. They both have the same goal—getting your pituitary gland (the pea-sized hormone hub in your brain) to release more GH—but they take different paths to get there.
Think of it like two different ways to wake up a roommate. One uses a specific alarm clock, and the other uses a gentle tap on the shoulder. Here is the breakdown of how they actually work based on the current data.
The veteran: Sermorelin
Sermorelin is often considered the reference standard in the compounding world. It is an analog of Growth Hormone Releasing Hormone (GHRH), which is just a fancy way of saying it mimics the natural signal your body already uses to trigger GH release.
- Evidence Grade: B+
- The Big Win: It was actually FDA-approved back in the 90s for diagnosing and treating children who were not growing properly.
- Safety Valves: It preserves the somatostatin feedback loop. In plain English, your body still has its natural brakes to prevent GH levels from getting too high.
- Brain Health: Scientists found positive results in two completed clinical trials focused on cognition (thinking and memory).
One weird thing: The original manufacturer stopped making it in 2008. Before you panic, it was not because of safety issues; it was just a supply chain problem. Because of this, there is no big company currently testing it for adult use, leaving us with some gaps in the data.
The specialist: Ipamorelin
Ipamorelin is a bit different. It is a selective ghrelin receptor agonist. Instead of mimicking GHRH, it mimics ghrelin to trigger short bursts of GH that last about two hours.
- Evidence Grade: B-
- Selectivity: This is its main claim to fame. It was the first compound found to be truly selective, meaning it triggers GH without messing with cortisol (your stress hormone) or prolactin (the hormone involved in milk production).
- The Reality Check: While it is great at being selective, it failed its clinical goals for gastrointestinal (GI) issues. Currently, there are no published human trials showing it actually changes body composition or burns fat.
What we still do not know
Scientists are still working on this one—turns out the human body is complicated. Who knew?
For example, you might see people suggesting you stack Ipamorelin with other peptides like CJC-1295. However, there is currently zero clinical trial evidence for that specific combination. Additionally, the FDA has flagged some safety concerns regarding how Ipamorelin is compounded, and it is on the WADA prohibited list for athletes.
Sermorelin also has gaps. While it has those positive brain studies, the main study for adult aging only had 19 people. That is a very small group to draw big conclusions from.
How to choose your path
This is a great one to bring up with your doctor. If you are curious about these compounds, you can find peptide-experienced physicians in our Find a Doctor directory. They can help you navigate the lack of head-to-head studies and explain how to find a peptide prescriber who understands your specific goals.
You can also explore other options and clinics through our peptide therapy near me resource to see what is available in your area.
This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.
Referenced Peptides
This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.